(Q58234865)
English
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis a
scientific article published on 01 August 2009
Statements
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis (English)
Tom W J Huizinga
E W Nivine Levarht
Andreea Ioan-Facsinay
Gerrie Stoeken-Rijsbergen
Michael P M van der Linden
1 August 2009